Document is current
Any future updates will be listed below
-
Authors
Feng, Yuqing
Barbulescu, Philip
Chana, Chetan K.
Shirdarreh, Melika
Yang, Hong
Wu, Lizhen
Mamand, Sami
Kashem, Mohammad
Zia, Amin
Han, Ming
Tsao, Julissa
Pugh, Trevor
Cescon, David
Schatz, David G.
Sicheri, Frank
Martin, Alberto
Pezo, Rossanna C.
-
Funding
Funding for this research was provided by:
York University
Canadian Institutes of Health Research (PJT-153307, PJT-178026, PJT-153307, PJT-153307, PJT-153307, PJT-178026, PJT-153307)
National Institutes of Health (R01-AI127642, R01-AI127642)
Sunnybrook Health Sciences Center
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 17 June 2025
First Online: 2 July 2025
Declarations
:
: The authors declare no competing interests.
: F.S is a founder and consultant for Repare Therapeutics and Induxion Therapeutics.
